Zhejiang Canaan Technology Limited
300412.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.26B
Close$
$-3.04
171.4% downside
Current Fair Value
171.4% downsideOvervalued by 171.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.26 Billion |
|---|---|
| Enterprise Value | $2.91 Billion |
| Dividend Yield | $0.06 (1.28%) |
| Earnings per Share | $0.06 |
| Beta | 0.58 |
| Outstanding Shares | 497,756,637 |
Return
| Return on Equity | 1.98% |
|---|---|
| Return on Assets | 0.81% |
| Return on Invested Capital | 0.79% |
Valuation & Multiples
| P/E Ratio | 111.82 |
|---|---|
| PEG | -266.81 |
| Price to Sales | 2.13 |
| Price to Book Ratio | 2.13 |
| Enterprise Value to Revenue | 2.48 |
| Enterprise Value to EBIT | 301.15 |
| Enterprise Value to Net Income | 143 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | 1.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Canaan Technology Limited
1,582 employees
CEO: Zheng Fang Zhejiang Canaan Technology Co., Ltd. is a Chinese enterprise specializing in the design, production, and sale of advanced pharmaceutical machinery. Its extensive product portfolio caters broadly to the pharmaceutical industry, particular...